Variations in the human CC chemokine eotaxin gene

Genes and Immunity

Volumn 2, Issue 8, 2001, Pages 461-463

  Miyamasu, M ^a,d   Sekiya, T ^a   Ohta, K ^e   Ra, C ^b   Yoshie, O ^c   Yamamoto, K ^a   Tsuchiya, N ^a   Tokunaga, K ^a   Hirai, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e NONE

Author keywords

Bronchial asthma; Eotaxin; Promoter; SNP

Indexed keywords

BETA CHEMOKINE; EOSINOPHIL CHEMOTACTIC FACTOR; EOTAXIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; ASTHMA; FEMALE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMINO ACID SUBSTITUTION; ASTHMA; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); VARIATION (GENETICS);

EID: 0035748601     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363807     Document Type: Article

References (15)

1. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schroder JM. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998; 160: 60-68.
2. Miyamasu M, Yamaguchi M, Nakajima T et al. Th1-derived cytokine interferon-gamma is a potent inhibitor of human eotaxin synthesis in vitro. Int Immunol 1999; 11: 1001-1004.
3. Nomiyama H, Mera A, Ohneda O, Miura R, Suda T, Yoshie O. Organization of the chemokine genes in the human and mouse major clusters of CC and CXC chemokines: diversification between the two species. Genes Immun 2001; 2: 110-113.
4. Matsukura S, Stellato C, Plitt JR et al. Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol 1999; 163: 6876-6883.
5. Kato H, Tsuchiya N, Izumi S et al. New variations of human CC-chemokine receptors CCR3 and CCR4. Genes Immun 1999; 1: 97-104.
6. Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000; 15: 7-12.
7. Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report II B, MD:National Institutes of Health 1997 (NIH publication no. 97-4051).
8. Hatta Y, Tsuchiya N, Ohashi J et. al. Association of Fc gamma receptor IIIB, but not of Fc gamma receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese. Genes Immun 1999; 1: 53-60.
9. Bidwell J, Keen L, Gallagher G et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999; 1: 3-19.
10. Cookson W. The alliance of genes and environment in asthma and allergy. Nature 1999; 402: B5-B11.
11. Shirakawa I, Deichmann KA, Izuhara I, Mao I, Adra CN, Hopkin JM. Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol Today 2000; 21: 60-64.
12. Nickel RG, Casolaro V, Wahn U et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 2000; 164: 1612-1616.
13. Nielsen H, Engelbrecht J, Brunak S, von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 1997; 10: 1-6.
14. Tenwillinger JD, Ott J. Handbook of Human Linkage Analysis. Johns Hopkins University Press: Baltimore, 1999, pp 188-193.
15. Lewontin RC. The interaction of selection and linkage. I. General considerations, heterotic models. Genetics 1964; 49: 49-67.